CIK 0000818686
- Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 39148213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,242,786
- in 10 filings, $10.6M under 10b5-1 plans
Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-03-12 | Nazzi Gianfranco EVP, Growth Markets Commercial | Option exercise | +883 | 8,775.36 | ||
| 2019-03-12 | Nazzi Gianfranco EVP, Growth Markets Commercial | Sale | −325 | $15.69 | $5K | 8,450.36 |
| 2019-03-12 | Nazzi Gianfranco EVP, Growth Markets Commercial | Option exercise · Restricted Share Units | −883 | 0 | ||
| 2019-03-12 | Griffin Deborah A Chief Accounting Officer | Option exercise | +953 | 953 | ||
| 2019-03-12 | Griffin Deborah A Chief Accounting Officer | Sale | −953 | $15.67 | $15K | 0 |
| 2019-03-12 | Griffin Deborah A Chief Accounting Officer | Option exercise · Restricted Share Units | −953 | 0 | ||
| 2019-03-12 | Dethlefs Sven EVP Global Marketing&Portfolio | Option exercise | +1,191 | 9,248.7 | ||
| 2019-03-12 | Dethlefs Sven EVP Global Marketing&Portfolio | Sale | −647 | $15.67 | $10K | 8,601.7 |
| 2019-03-12 | Dethlefs Sven EVP Global Marketing&Portfolio | Option exercise · Restricted Share Units | −1,191 | 0 | ||
| 2019-03-12 | Daniell Richard Exec. VP, European Commercial | Option exercise | +715 | 715 | ||
| 2019-03-12 | Daniell Richard Exec. VP, European Commercial | Sale | −715 | $15.69 | $11K | 0 |
| 2019-03-12 | Daniell Richard Exec. VP, European Commercial | Option exercise · Restricted Share Units | −715 | 0 | ||
| 2019-03-04 | Stark David Matthew Exec. VP Chief Legal Officer | Grant or award · Restricted Share Units | +41,791 | 41,791 | ||
| 2019-03-04 | Schultz Kare President and CEO | Grant or award · Restricted Share Units | +179,104 | 179,104 | ||
| 2019-03-04 | Sabag Mark EVP, Global Human Resources | Grant or award · Restricted Share Units | +47,761 | 47,761 | ||
| 2019-03-04 | O'Grady Brendan P. EVP, North America Commercial | Grant or award · Restricted Share Units | +56,716 | 56,716 | ||
| 2019-03-04 | Nazzi Gianfranco EVP, Growth Markets Commercial | Grant or award · Restricted Share Units | +38,805 | 38,805 | ||
| 2019-03-04 | McClellan Michael James EVP, Chief Financial Officer | Grant or award · Restricted Share Units | +50,746 | 50,746 | ||
| 2019-03-04 | Griffin Deborah A Chief Accounting Officer | Grant or award · Restricted Share Units | +19,321 | 19,321 | ||
| 2019-03-04 | Fridriksdottir Hafrun Executive VP, Global R&D | Grant or award · Restricted Share Units | +56,716 | 56,716 |
Page 66 of 76 · 1,517 trades